Company Monitoring Page for Arqule

latest headlines for company on cafepharma

Cancer Cures: ASCO Stocks to Give Your Portfolio a Boost
Motley Fool
Sat, 03/24/12 - 11:30 am
Tags:
Celldex, Arqule, JNJ, Ariad Pharmaceuticals, Aveo Pharmaceutical
7 Cancer Drug Stocks to Know Right Now
Seeking Alpha
Wed, 03/14/12 - 10:54 am
Tags:
Seattle Genetics, Celldex, Arqule, Daiichi Sankyo, JNJ, Medivation, Dendreon, Aveo Pharmaceutical, Ariad Pharmaceuticals, AstraZeneca, Array Biopharma, Oncothyreon
ArQule license deal with Daiichi could land $265M
Bizjournals.com
Thu, 11/10/11 - 01:09 pm
Tags:
Arqule, Daiichi Sankyo, kinase inhibitors
3 Clear Winners of ESMO 2010
Seeking Alpha
Mon, 10/25/10 - 10:35 am
Tags:
ESMO, cancer, Aveo Pharmaceutical, Arqule, Dendreon, Immunogen, Roche, Medarex, Seattle Genetics, Sanofi
Pfizer Failure Clears Way for Small Biotech ArQule
Minyanville
Tue, 08/24/10 - 01:48 pm
Tags:
Pfizer, Sutent, Arqule, small cell lung cancer
ArQule: Warming Up or Cooling Off?
Motley Fool
Fri, 08/6/10 - 07:28 am
Tags:
Arqule
Jury Still Out on Exelixis's Long Term Potential
Seeking Alpha
Mon, 07/26/10 - 10:56 am
Tags:
Sanofi, Novartis, GSK, Exelixis, cancer, Bristol-Myers Squibb, Arqule
ArQule says drug candidate could benefit subgroup of lung cancer patients
Yahoo/AP
Mon, 06/7/10 - 08:03 am
Tags:
lung cancer, Arqule
ASCO - A Big Deal For Biotechs
Investopedia
Thu, 05/27/10 - 10:05 am
Tags:
ASCO, biotech, Abbott Laboratories, Ariad Pharmaceuticals, Arqule, Bristol-Myers Squibb, Keryx, Nektar, Merck, Vanda, Aeterna Zentaris
ASCO Abstracts -- Pops and Drops!
Motley Fool
Mon, 05/24/10 - 04:30 pm
Tags:
ASCO, Keryx, Ziopharm, Celldex, Arqule, Delcath, Biogen Idec, Celgene, Bristol-Myers Squibb
Arqule Joins the Phase III Club
Seeking Alpha
Wed, 04/14/10 - 07:44 am
Tags:
Arqule, Tarceva, lung cancer, clinical trials, Exelixis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.